This report studies the global market size of Levothyroxine Sodium in key regions like North America, Europe, China and Japan, focuses on the consumption of Levothyroxine Sodium in these regions.
This research report categorizes the global Levothyroxine Sodium market by top players/brands, region, type and end user. This report also studies the global Levothyroxine Sodium market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Abbvie
Mylan Pharma
Merck
Pfizer
Lannett Company
Novartis
Fresenius Kabi
IBSA
Piramal Critical Care
Abbott
Levothyroxine Sodium market size by Type
Oral
Injection
Oral had a market share of 99% in 2018.
Levothyroxine Sodium market size by Applications
Hospitals
Pharmacy
Others
Pharmacy is the greatest segment of Levothyroxine Sodium application, with a share of 63% in 2018.
Market size by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Levothyroxine Sodium market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Levothyroxine Sodium market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Levothyroxine Sodium companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Levothyroxine Sodium submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Levothyroxine Sodium are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (M Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Levothyroxine Sodium market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
This research report categorizes the global Levothyroxine Sodium market by top players/brands, region, type and end user. This report also studies the global Levothyroxine Sodium market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Abbvie
Mylan Pharma
Merck
Pfizer
Lannett Company
Novartis
Fresenius Kabi
IBSA
Piramal Critical Care
Abbott
Levothyroxine Sodium market size by Type
Oral
Injection
Oral had a market share of 99% in 2018.
Levothyroxine Sodium market size by Applications
Hospitals
Pharmacy
Others
Pharmacy is the greatest segment of Levothyroxine Sodium application, with a share of 63% in 2018.
Market size by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Levothyroxine Sodium market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Levothyroxine Sodium market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Levothyroxine Sodium companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Levothyroxine Sodium submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Levothyroxine Sodium are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (M Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Levothyroxine Sodium market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
1.1 Levothyroxine Sodium Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Levothyroxine Sodium Market Size Growth Rate by Type
1.4.2 Oral
1.4.3 Injection
1.5 Market by Application
1.5.1 Global Levothyroxine Sodium Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Pharmacy
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Levothyroxine Sodium Market Size
2.1.1 Global Levothyroxine Sodium Revenue 2014-2025
2.1.2 Global Levothyroxine Sodium Sales 2014-2025
2.2 Levothyroxine Sodium Growth Rate by Regions
2.2.1 Global Levothyroxine Sodium Sales by Regions
2.2.2 Global Levothyroxine Sodium Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Levothyroxine Sodium Sales by Manufacturers
3.1.1 Levothyroxine Sodium Sales by Manufacturers
3.1.2 Levothyroxine Sodium Sales Market Share by Manufacturers
3.2 Levothyroxine Sodium Revenue by Manufacturers
3.2.1 Levothyroxine Sodium Revenue by Manufacturers (2014-2019)
3.2.2 Levothyroxine Sodium Revenue Share by Manufacturers (2014-2019)
3.3 Levothyroxine Sodium Price by Manufacturers
3.4 Levothyroxine Sodium Manufacturing Base Distribution, Product Types
3.4.1 Levothyroxine Sodium Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Levothyroxine Sodium Product Type
3.4.3 Date of International Manufacturers Enter into Levothyroxine Sodium Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Levothyroxine Sodium Sales by Type
4.2 Global Levothyroxine Sodium Revenue by Type
4.3 Levothyroxine Sodium Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Levothyroxine Sodium Breakdown Data by Application
6 North America
6.1 North America Levothyroxine Sodium by Country
6.1.1 North America Levothyroxine Sodium Sales by Country
6.1.2 North America Levothyroxine Sodium Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Levothyroxine Sodium by Type
6.3 North America Levothyroxine Sodium by Application
7 Europe
7.1 Europe Levothyroxine Sodium by Country
7.1.1 Europe Levothyroxine Sodium Sales by Country
7.1.2 Europe Levothyroxine Sodium Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Levothyroxine Sodium by Type
7.3 Europe Levothyroxine Sodium by Application
8 Asia Pacific
8.1 Asia Pacific Levothyroxine Sodium by Region
8.1.1 Asia Pacific Levothyroxine Sodium Sales by Region
8.1.2 Asia Pacific Levothyroxine Sodium Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Thailand
8.1.10 Malaysia
8.1.11 Philippines
8.1.12 Vietnam
8.2 Asia Pacific Levothyroxine Sodium by Type
8.3 Asia Pacific Levothyroxine Sodium by Application
9 Central & South America
9.1 Central & South America Levothyroxine Sodium by Country
9.1.1 Central & South America Levothyroxine Sodium Sales by Country
9.1.2 Central & South America Levothyroxine Sodium Revenue by Country
9.1.3 Brazil
9.2 Central & South America Levothyroxine Sodium by Type
9.3 Central & South America Levothyroxine Sodium by Application
10 Middle East and Africa
10.1 Middle East and Africa Levothyroxine Sodium by Country
10.1.1 Middle East and Africa Levothyroxine Sodium Sales by Country
10.1.2 Middle East and Africa Levothyroxine Sodium Revenue by Country
10.1.3 Turkey
10.1.4 GCC Countries
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Levothyroxine Sodium by Type
10.3 Middle East and Africa Levothyroxine Sodium by Application
11 Company Profiles
11.1 Abbvie
11.1.1 Abbvie Company Details
11.1.2 Company Business Overview
11.1.3 Abbvie Levothyroxine Sodium Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Abbvie Levothyroxine Sodium Products Offered
11.1.5 Abbvie Recent Development
11.2 Mylan Pharma
11.2.1 Mylan Pharma Company Details
11.2.2 Company Business Overview
11.2.3 Mylan Pharma Levothyroxine Sodium Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Mylan Pharma Levothyroxine Sodium Products Offered
11.2.5 Mylan Pharma Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Company Business Overview
11.3.3 Merck Levothyroxine Sodium Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Merck Levothyroxine Sodium Products Offered
11.3.5 Merck Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Company Business Overview
11.4.3 Pfizer Levothyroxine Sodium Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Pfizer Levothyroxine Sodium Products Offered
11.4.5 Pfizer Recent Development
11.5 Lannett Company
11.5.1 Lannett Company Company Details
11.5.2 Company Business Overview
11.5.3 Lannett Company Levothyroxine Sodium Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Lannett Company Levothyroxine Sodium Products Offered
11.5.5 Lannett Company Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Company Business Overview
11.6.3 Novartis Levothyroxine Sodium Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Novartis Levothyroxine Sodium Products Offered
11.6.5 Novartis Recent Development
11.7 Fresenius Kabi
11.7.1 Fresenius Kabi Company Details
11.7.2 Company Business Overview
11.7.3 Fresenius Kabi Levothyroxine Sodium Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Fresenius Kabi Levothyroxine Sodium Products Offered
11.7.5 Fresenius Kabi Recent Development
11.8 IBSA
11.8.1 IBSA Company Details
11.8.2 Company Business Overview
11.8.3 IBSA Levothyroxine Sodium Sales, Revenue and Gross Margin (2014-2019)
11.8.4 IBSA Levothyroxine Sodium Products Offered
11.8.5 IBSA Recent Development
11.9 Piramal Critical Care
11.9.1 Piramal Critical Care Company Details
11.9.2 Company Business Overview
11.9.3 Piramal Critical Care Levothyroxine Sodium Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Piramal Critical Care Levothyroxine Sodium Products Offered
11.9.5 Piramal Critical Care Recent Development
11.10 Abbott
11.10.1 Abbott Company Details
11.10.2 Company Business Overview
11.10.3 Abbott Levothyroxine Sodium Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Abbott Levothyroxine Sodium Products Offered
11.10.5 Abbott Recent Development
12 Future Forecast
12.1 Levothyroxine Sodium Market Forecast by Regions
12.1.1 Global Levothyroxine Sodium Sales Forecast by Regions 2019-2025
12.1.2 Global Levothyroxine Sodium Revenue Forecast by Regions 2019-2025
12.2 Levothyroxine Sodium Market Forecast by Type
12.2.1 Global Levothyroxine Sodium Sales Forecast by Type 2019-2025
12.2.2 Global Levothyroxine Sodium Revenue Forecast by Type 2019-2025
12.3 Levothyroxine Sodium Market Forecast by Application
12.4 North America Levothyroxine Sodium Forecast
12.5 Europe Levothyroxine Sodium Forecast
12.6 Asia Pacific Levothyroxine Sodium Forecast
12.7 Central & South America Levothyroxine Sodium Forecast
12.8 Middle East and Africa Levothyroxine Sodium Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Levothyroxine Sodium Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
1 Study Coverage
1.1 Levothyroxine Sodium Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Levothyroxine Sodium Market Size Growth Rate by Type
1.4.2 Oral
1.4.3 Injection
1.5 Market by Application
1.5.1 Global Levothyroxine Sodium Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Pharmacy
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Levothyroxine Sodium Market Size
2.1.1 Global Levothyroxine Sodium Revenue 2014-2025
2.1.2 Global Levothyroxine Sodium Sales 2014-2025
2.2 Levothyroxine Sodium Growth Rate by Regions
2.2.1 Global Levothyroxine Sodium Sales by Regions
2.2.2 Global Levothyroxine Sodium Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Levothyroxine Sodium Sales by Manufacturers
3.1.1 Levothyroxine Sodium Sales by Manufacturers
3.1.2 Levothyroxine Sodium Sales Market Share by Manufacturers
3.2 Levothyroxine Sodium Revenue by Manufacturers
3.2.1 Levothyroxine Sodium Revenue by Manufacturers (2014-2019)
3.2.2 Levothyroxine Sodium Revenue Share by Manufacturers (2014-2019)
3.3 Levothyroxine Sodium Price by Manufacturers
3.4 Levothyroxine Sodium Manufacturing Base Distribution, Product Types
3.4.1 Levothyroxine Sodium Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Levothyroxine Sodium Product Type
3.4.3 Date of International Manufacturers Enter into Levothyroxine Sodium Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Levothyroxine Sodium Sales by Type
4.2 Global Levothyroxine Sodium Revenue by Type
4.3 Levothyroxine Sodium Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Levothyroxine Sodium Breakdown Data by Application
6 North America
6.1 North America Levothyroxine Sodium by Country
6.1.1 North America Levothyroxine Sodium Sales by Country
6.1.2 North America Levothyroxine Sodium Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Levothyroxine Sodium by Type
6.3 North America Levothyroxine Sodium by Application
7 Europe
7.1 Europe Levothyroxine Sodium by Country
7.1.1 Europe Levothyroxine Sodium Sales by Country
7.1.2 Europe Levothyroxine Sodium Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Levothyroxine Sodium by Type
7.3 Europe Levothyroxine Sodium by Application
8 Asia Pacific
8.1 Asia Pacific Levothyroxine Sodium by Region
8.1.1 Asia Pacific Levothyroxine Sodium Sales by Region
8.1.2 Asia Pacific Levothyroxine Sodium Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Thailand
8.1.10 Malaysia
8.1.11 Philippines
8.1.12 Vietnam
8.2 Asia Pacific Levothyroxine Sodium by Type
8.3 Asia Pacific Levothyroxine Sodium by Application
9 Central & South America
9.1 Central & South America Levothyroxine Sodium by Country
9.1.1 Central & South America Levothyroxine Sodium Sales by Country
9.1.2 Central & South America Levothyroxine Sodium Revenue by Country
9.1.3 Brazil
9.2 Central & South America Levothyroxine Sodium by Type
9.3 Central & South America Levothyroxine Sodium by Application
10 Middle East and Africa
10.1 Middle East and Africa Levothyroxine Sodium by Country
10.1.1 Middle East and Africa Levothyroxine Sodium Sales by Country
10.1.2 Middle East and Africa Levothyroxine Sodium Revenue by Country
10.1.3 Turkey
10.1.4 GCC Countries
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Levothyroxine Sodium by Type
10.3 Middle East and Africa Levothyroxine Sodium by Application
11 Company Profiles
11.1 Abbvie
11.1.1 Abbvie Company Details
11.1.2 Company Business Overview
11.1.3 Abbvie Levothyroxine Sodium Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Abbvie Levothyroxine Sodium Products Offered
11.1.5 Abbvie Recent Development
11.2 Mylan Pharma
11.2.1 Mylan Pharma Company Details
11.2.2 Company Business Overview
11.2.3 Mylan Pharma Levothyroxine Sodium Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Mylan Pharma Levothyroxine Sodium Products Offered
11.2.5 Mylan Pharma Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Company Business Overview
11.3.3 Merck Levothyroxine Sodium Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Merck Levothyroxine Sodium Products Offered
11.3.5 Merck Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Company Business Overview
11.4.3 Pfizer Levothyroxine Sodium Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Pfizer Levothyroxine Sodium Products Offered
11.4.5 Pfizer Recent Development
11.5 Lannett Company
11.5.1 Lannett Company Company Details
11.5.2 Company Business Overview
11.5.3 Lannett Company Levothyroxine Sodium Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Lannett Company Levothyroxine Sodium Products Offered
11.5.5 Lannett Company Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Company Business Overview
11.6.3 Novartis Levothyroxine Sodium Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Novartis Levothyroxine Sodium Products Offered
11.6.5 Novartis Recent Development
11.7 Fresenius Kabi
11.7.1 Fresenius Kabi Company Details
11.7.2 Company Business Overview
11.7.3 Fresenius Kabi Levothyroxine Sodium Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Fresenius Kabi Levothyroxine Sodium Products Offered
11.7.5 Fresenius Kabi Recent Development
11.8 IBSA
11.8.1 IBSA Company Details
11.8.2 Company Business Overview
11.8.3 IBSA Levothyroxine Sodium Sales, Revenue and Gross Margin (2014-2019)
11.8.4 IBSA Levothyroxine Sodium Products Offered
11.8.5 IBSA Recent Development
11.9 Piramal Critical Care
11.9.1 Piramal Critical Care Company Details
11.9.2 Company Business Overview
11.9.3 Piramal Critical Care Levothyroxine Sodium Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Piramal Critical Care Levothyroxine Sodium Products Offered
11.9.5 Piramal Critical Care Recent Development
11.10 Abbott
11.10.1 Abbott Company Details
11.10.2 Company Business Overview
11.10.3 Abbott Levothyroxine Sodium Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Abbott Levothyroxine Sodium Products Offered
11.10.5 Abbott Recent Development
12 Future Forecast
12.1 Levothyroxine Sodium Market Forecast by Regions
12.1.1 Global Levothyroxine Sodium Sales Forecast by Regions 2019-2025
12.1.2 Global Levothyroxine Sodium Revenue Forecast by Regions 2019-2025
12.2 Levothyroxine Sodium Market Forecast by Type
12.2.1 Global Levothyroxine Sodium Sales Forecast by Type 2019-2025
12.2.2 Global Levothyroxine Sodium Revenue Forecast by Type 2019-2025
12.3 Levothyroxine Sodium Market Forecast by Application
12.4 North America Levothyroxine Sodium Forecast
12.5 Europe Levothyroxine Sodium Forecast
12.6 Asia Pacific Levothyroxine Sodium Forecast
12.7 Central & South America Levothyroxine Sodium Forecast
12.8 Middle East and Africa Levothyroxine Sodium Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Levothyroxine Sodium Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
